跳至主要内容
临床试验/2024-514550-73-00
2024-514550-73-00招募中2 期

Intravenous dexmedetomidine as an adjuvant to locoregional anesthesia in pediatric surgery: a prospective, randomized, double-blind, placebo-controlled study. DEXPED

Centre Hospitalier Universitaire De Montpellier2 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2024年11月5日最近更新:
相关药物

试验速览

阶段
2 期
状态
招募中
入组人数
200
试验地点
2
主要终点
Number of patients using a rescue analgesic (Nalbuphine, Nubain®) in the PACU between the two arms

研究概览

简要总结

To study the impact of intravenous (IV) dexmedetomidine combined with locoregional anesthesia (LRA) on postoperative pain in children undergoing surgery

入排标准

年龄范围
0 years 至 17 years(0-17 Years)
接受健康志愿者

入选标准

  • Age 1 to 7 years old male or female
  • To be hospitalized for scheduled urovisceral orchidopexy or peritoneovaginal canal surgery (inguinal hernia or hydrocele cure) on an outpatient basis
  • Locoregional anesthesia via Transversus Abdominis Plane (TAP) block and/or pudendal block
  • National health insurance coverage
  • Signed informed consent from holders of parental authority
  • American Society of Anesthesiology (ASA) score: 1-2
  • French read, written and spoken by legal representatives

排除标准

  • Patients under 1 or over 8 years old
  • Patients with allergies to local anesthetics
  • Patients with a contraindication to locoregional anesthesia: coagulation disorder or infection (fasciocutaneous) in the puncture zone
  • Patients with a contraindication to dexmedetomidine (hypersensitivity to the active ingredient or one of the excipients, advanced heart block (level 2 or 3), uncontrolled hypotension, acute cerebrovascular pathologies)
  • Patients with delayed psychological development, cognitive or behavioral disorders, or severe neurological pathology
  • Patients and/or parents who refused to participate in the study
  • Proven allergy or contraindication to dexmedetomidine or nalbuphine
  • Previous study participants

结局指标

主要结局

Number of patients using a rescue analgesic (Nalbuphine, Nubain®) in the PACU between the two arms

Number of patients using a rescue analgesic (Nalbuphine, Nubain®) in the PACU between the two arms

次要结局

  • Assessment of postoperative pain using the Face Legs Activity Cry Consolability (FLACC) scale: on admission and every 15 minutes until discharge from the PACU, then before returning home
  • Intraoperative morphine consumption: Sufentanil, number of re-injections (0.1 µg/kg) required
  • Dose in milligrams of emergency analgesics in the PACU
  • Incidence of opioid-related side effects (respiratory complications, postoperative nausea and vomiting)
  • Length of stay (from PACU entry to discharge based on Aldrete score > 9)
  • Incidence of emergence delirium in the PACU according to the Pediatric Anesthesia Emergence Delirium (PAED) scale
  • Post-Hospitalization Behavior Questionnaire at 7 days, 3, and 6 months
  • Postoperative Pain Measure For Parents at 7 days, 3, and 6 months
  • Post-operative quality of life questionnaire pedsQL at 7 days, 3 and 6 months

研究者

申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

ISSA Amelle

Scientific

Centre Hospitalier Universitaire De Montpellier

研究点 (2)

Loading locations...

相似试验